New developments in anemia management in chronic kidney disease.
Amerling
Richard
R
Beth Israel Medical Center NewYork, NewYork, USA.
Besarab
Anatole
A
Roy
Cindy
C
D000740:Anemia / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D023181:Antimicrobial Cationic Peptides / Q000502:physiology; D002986:Clinical Trials as Topic; D016903:Drug Monitoring; D004921:Erythropoietin / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006454:Hemoglobins / Q000378:metabolism; D064451:Hepcidins; D006706:Homeostasis; D006801:Humans; D007501:Iron / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000150:complications*; D009398:Nephrology / Q000379:methods* / Q000639:trends; D012307:Risk Factors
D023181:Antimicrobial Cationic Peptides; D006397:Hematinics; D006454:Hemoglobins; D064451:Hepcidins; D004921:Erythropoietin; D007501:Iron